BC Platforms announced yesterday that it has partnered with personalized medicine firm Codigo 46 to support the establishment of a large-scale biobank of genetic and phenotypic data samples from Mexican individuals.
Under the terms of the deal, BC Platforms will provide Cuernavaca, Mexico-based Codigo46 with a custom technology platform to allow its customers and collaborators to securely access and analyze the biobank’s data, as well as to enable the acquisition of large volumes of data from new sources.
Additional terms of the agreement were not disclosed.
“Our ambitions are not just to generate a genetic database, but also to incorporate clinical data from hospital systems with patient consent and be a part of different research projects,” Codigo46 CEO Lorenza Haddad said in a statement. “It will be the first biobank to provide such extensive data sets rom subjects of this diverse genotype, and we expect it will be a highly valuable resource for academic and commercial research across the globe.”
The deal with Codigo 46 marks the latest in a series of such arrangements BC Platforms has struck recently. Last month, it signed a deal to provide genomic data management and analysis services to Monash University. And in January, the company partnered with Auria Biobank to develop a genomic data management system for the Finnish biorepository’s collection of human samples.